Anika Therapeutics, Inc. (ANIK) stock
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$12.85−0.07 (-0.54%)
Close on Nov 17, 2026Market cap $171.97MP/E –Yield –
Anika Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Anika Therapeutics's total assets was $183.47M at Jun 30, 2026. For fiscal 2025 it was $190.27M, down 6.2% from the year before. Over ten years it grew -2.1% a year on average. The highest annual figure on record is $365.61M in fiscal 2020.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $190.27M | -6.2% |
| FY2024 | Dec 31, 2024 | $202.74M | -25.1% |
| FY2023 | Dec 31, 2023 | $270.63M | -22.5% |
| FY2022 | Dec 31, 2022 | $349.13M | +0.5% |
| FY2021 | Dec 31, 2021 | $347.54M | -4.9% |
| FY2020 | Dec 31, 2020 | $365.61M | +10.6% |
| FY2019 | Dec 31, 2019 | $330.71M | +18.5% |
| FY2018 | Dec 31, 2018 | $278.99M | -1.3% |
| FY2017 | Dec 31, 2017 | $282.62M | +17.6% |
| FY2016 | Dec 31, 2016 | $240.25M | +1.9% |
| FY2015 | Dec 31, 2015 | $235.75M | +22.3% |
| FY2014 | Dec 31, 2014 | $192.81M | +23.6% |
| FY2013 | Dec 31, 2013 | $156.04M | +9.8% |
| FY2012 | Dec 31, 2012 | $142.07M | +6.9% |
| FY2011 | Dec 31, 2011 | $132.84M | +3.0% |
| FY2010 | Dec 31, 2010 | $128.94M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $183.47M | -2.2% |
| Q1 FY2026 | Mar 31, 2026 | $179.39M | -5.9% |
| Q4 FY2025 | Dec 31, 2025 | $190.27M | -6.2% |
| Q3 FY2025 | Sep 30, 2025 | $189.44M | -18.1% |
| Q2 FY2025 | Jun 30, 2025 | $187.68M | -28.5% |
| Q1 FY2025 | Mar 31, 2025 | $190.61M | -27.7% |
| Q4 FY2024 | Dec 31, 2024 | $202.74M | -25.1% |
| Q3 FY2024 | Sep 30, 2024 | $231.41M | -29.5% |
| Q2 FY2024 | Jun 30, 2024 | $262.66M | -20.1% |
| Q1 FY2024 | Mar 31, 2024 | $263.74M | -22.2% |
| Q4 FY2023 | Dec 31, 2023 | $270.63M | -22.5% |
| Q3 FY2023 | Sep 30, 2023 | $328.16M | -5.6% |
| Q2 FY2023 | Jun 30, 2023 | $328.88M | -7.1% |
| Q1 FY2023 | Mar 31, 2023 | $339.07M | -0.9% |
| Q4 FY2022 | Dec 31, 2022 | $349.13M | +0.5% |
| Q3 FY2022 | Sep 30, 2022 | $347.75M | -1.5% |
| Q2 FY2022 | Jun 30, 2022 | $354.12M | -2.5% |
| Q1 FY2022 | Mar 31, 2022 | $342.24M | -5.5% |
| Q4 FY2021 | Dec 31, 2021 | $347.54M | -4.9% |
| Q3 FY2021 | Sep 30, 2021 | $352.93M | -15.2% |
| Q2 FY2021 | Jun 30, 2021 | $363.13M | -17.6% |
| Q1 FY2021 | Mar 31, 2021 | $362.25M | -9.2% |
| Q4 FY2020 | Dec 31, 2020 | $365.61M | +10.6% |
| Q3 FY2020 | Sep 30, 2020 | $416.34M | +30.3% |
| Q2 FY2020 | Jun 30, 2020 | $440.53M | +53.3% |
| Q1 FY2020 | Mar 31, 2020 | $398.91M | +30.1% |
| Q4 FY2019 | Dec 31, 2019 | $330.71M | +18.5% |
| Q3 FY2019 | Sep 30, 2019 | $319.58M | +18.7% |
| Q2 FY2019 | Jun 30, 2019 | $287.36M | +8.3% |
| Q1 FY2019 | Mar 31, 2019 | $306.66M | +7.9% |
| Q4 FY2018 | Dec 31, 2018 | $278.99M | -1.3% |
| Q3 FY2018 | Sep 30, 2018 | $269.26M | -1.4% |
| Q2 FY2018 | Jun 30, 2018 | $265.41M | +0.2% |
| Q1 FY2018 | Mar 31, 2018 | $284.34M | +14.9% |
| Q4 FY2017 | Dec 31, 2017 | $282.62M | +17.6% |
| Q3 FY2017 | Sep 30, 2017 | $273.13M | +18.2% |
| Q2 FY2017 | Jun 30, 2017 | $265.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $247.37M | – |
| Q4 FY2016 | Dec 31, 2016 | $240.25M | – |
| Q3 FY2016 | Sep 30, 2016 | $231.06M | – |
See a number that looks wrong?